profit from every $100 of sales.
$0$100
SkyAI
We have no price for SkyAI since 17 July 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$1.15-0.43% today
-79.9% since Oct 13, 25
1-year low $0.951-year high $5.78
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What SkyAI sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $204,120 in 2025, with -$283 million of profit last year.
SalesProfit
SkyAI vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| SkyAI | No profit yet | ||
 ResMed | 22.1× · Fair price | ||
 West Pharmaceutical Services | 58.8× · Expensive | ||
 Hologic | 30.0× · Fair price | ||
 Baxter International | No profit yet |
AI analysis
An AI analyst reads SkyAI's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | 0 | -0 | |
| -9 | -10 | -6 | -13 | |
| -8 | -9 | -4 | -270 | |
| -5 | -10 | -9 | -283 | |
| -3,762.00 | -4,983.00 | -2,219.92 | -11.16 | |
| – | – | – | -202.5% | |
| – | – | – | -6,512.1% | |
| – | – | – | -138,400.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 12 | 12 | 7 | 269 |
| Cash | 4 | 3 | 1 | 10 |
| Total debt | – | – | 4 | 3 |
| Total liabilities | 2 | 4 | 5 | 5 |
| 10 | 8 | 2 | 264 | |
| 0 | 0 | 0 | 25 | |
| -71.6% | -100.8% | -48.8% | -79.7% | |
| -48.1% | -124.0% | -465.7% | -106.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -6 | -9 | -4 | -11 | |
| 1 | 1 | 0 | 171 | |
| -7 | -9 | -4 | -182 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 1 | 1 | 107 |
Valuation
- –
- –
- –
- –
- 381.5×
- –
- –
- -233.1%
- -362.8%
- –
Profitability
- -202.5%
- -6,512.1%
- -138,400.0%
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -1.19 | – | – |
| Mar 31, 2026 | -1.00 | -0.01 | −15,283.1% |
| Nov 14, 2025 | -4.02 | -1.01 | −298.0% |
| Aug 13, 2025 | 3.58 | -0.94 | +480.9% |
| May 15, 2025 | 38.62 | – | – |
| Mar 27, 2025 | -869.70 | -198.00 | −339.2% |
| Nov 14, 2024 | -1.27 | -0.88 | −44.3% |
| Aug 14, 2024 | -2.20 | -0.88 | −150.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
10No pass
Benjamin Graham
18No pass
Philip Fisher
15No pass
Peter Lynch
10No pass
Joel Greenblatt
33No pass
Charlie Munger
4No pass
Terry Smith
10No pass
Questions about SkyAI
Is SkyAI a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the SkyAI AI analysis
What does SkyAI do?
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. It is in Medical - Instruments & Supplies.
Does SkyAI pay a dividend?
No. SkyAI does not pay a dividend at the moment.
Who are SkyAI's competitors?
The largest listed companies in the same industry are ResMed, West Pharmaceutical Services, Hologic and Baxter International. The peers table on this page compares their profit, growth and price with SkyAI's.
Prices: daily closes to Jul 17, 2026. Fundamentals: company reports via invest-like data.